secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOVIE INC. (BIVI)
CIK:        0001580149
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001520138-25-000347
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioVie shareholders re-elect six directors, ratify auditor, approve equity plan increase
--------------------------------------------------------------------------------

- All 6 nominees elected for one-year terms; Amy Chappell received 1,517,109 for, 36,239 withhold.
- Ratification of EisnerAmper LLP as independent auditor for FY2026: 3,245,049 for, 141,868 against.
- Amendment to 2019 Omnibus Equity Incentive Plan approved: 1,340,062 for, 207,794 against; broker non-votes 1,864,509.
- Equity plan authorized shares increased to 3,100,000, nearly doubling current authorized pool.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580149/000152013825000347/0001520138-25-000347-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580149/000152013825000347/bivi-20251110_8k.htm
  HTML page:      https://secwatch.observer/filing/0001520138-25-000347

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer